Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the fourth quarter and full year ended December 31, 2024.
Q4 revenue of $93.5 million, at the upper end of our guidance rangeQ4 net loss of $1.0 million, or $(0.05) per share; Non-GAAP EPS of $0.50, at ...